Comparator: FMI sitagliptin/metformin 50 mg/1000 mg FDC tablet

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Type 2 Diabetes

Phase 1

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)

CompletedNCT00961857

Merck Sharp & Dohme LLCType 2 Diabetes

Start: 2005-12-01End: 2006-01-01Updated: 2019-11-13

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)

CompletedNCT00961480

Merck Sharp & Dohme LLCType 2 Diabetes

Start: 2007-10-31End: 2007-11-30Updated: 2015-06-09